ListarMED_Articles por tema "heart failure"

Mostrando ítems 1-6 de 6

    • openAccess   Changes in myocardial iron content following administration of intravenous iron (Myocardial‐IRON): Study design 

      Miñana, Gema; Cardells, Ingrid; Palau, Patricia; Llàcer, Pau; Facila Rubio, Lorenzo; Almenar, Luis; López‐Lereu, Maria Pilar; Monmeneu, Jose V.; Amiguet, Martina; González, Jessika; Serrano, Alicia; Montagud, Vicente; López‐Vilella, Raquel; Valero, Ernesto; García-Blas, Sergio; Bodí, Vicent; De la Espriella, Rafael; Sanchis, Juan; Chorro, Francisco J.; Bayes-Genis, Antoni; Núñez, Julio; Myocardial‐IRON Investigators Wiley (2018)
      Treatment with intravenous ferric carboxymaltose (FCM) has been shown to improve symptoms, functional capacity, and quality of life in patients with heart failure and iron deficiency. However, the underlying mechanisms for ...

    • openAccess   Heart Failure Prevalence Rates and Its Association with Other Cardiovascular Diseases and Chronic Kidney Disease: SIMETAP-HF Study 

      Ruiz-Garcia, Antonio; Serrano-Cumplido, Adalberto; Escobar, Carlos; Arranz-Martínez, Ezequiel; Turégano-Yedro, Miguel; Pallarés-Carratalá, Vicente Multidisciplinary Digital Publishing Institute (MDPI) (2023-07-26)
      ntroduction and objectives: Heart failure (HF) is a major health problem that causes high mortality and hospitalization rates. This study aims to determine the HF prevalence rates in populations aged both ≥18 years and ≥50 ...

    • openAccess   Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial-IRON Trial 

      Núñez, Julio; Miñana, Gema; Cardells, Ingrid; Palau, Patricia; Llàcer, Pau; Facila Rubio, Lorenzo; Almenar-Bonet, Luis; Lopez-Lereu, Maria Pilar; Monmeneu Menadas, Jose Vicente; Amiguet Comins, Martina; González, Jessika; Serrano, Alicia; Montagud, Vicente; López‐Vilella, Raquel; Valero, Ernesto; García-Blas, Sergio; Bodí, Vicent; De la Espriella, Rafael; Lupón, Josep; Navarro, Jorge; Górriz, José Luis; Sanchis, Juan American Heart Association (2020-02-13)
      Background Intravenous ferric carboxymaltose (FCM) improves symptoms, functional capacity, and quality of life in heart failure and iron deficiency. The mechanisms underlying these effects are not fully understood. The ...

    • closedAccess   Posicionamiento SEMERGEN en el abordaje de la insuficiencia cardíaca crónica en atención primaria 

      Castillo Moraga, María José; Turégano-Yedro, Miguel; Pallarés-Carratalá, Vicente; Seoane-Vicente, M.C.; Serrano-Cumplido, A.; Ruiz-García, A.; Martin-Rioobó, E.; Escobar-Cervantes, C.; Polo-García, J.; Barrios, V. Elsevier (2022)
      La insuficiencia cardíaca (IC) es un problema de salud pública que genera una gran carga asistencial tanto hospitalaria como en atención primaria (AP). La publicación de numerosos estudios sobre IC durante los últimos ...

    • openAccess   Vitamin D supplementation and Its impact on mortality and cardiovascular outcomes: systematic review and meta-analysis of 80 randomized clinical trials 

      Ruiz-Garcia, Antonio; Pallarés-Carratalá, Vicente; Turégano-Yedro, Miguel; Torres, Ferran; Sapena, Víctor; Martin-Gorgojo, Alejandro; Martin-Moreno, Jose M. MDPI (2023-04-07)
      Background: The impact of vitamin D supplementation on cardiovascular outcomes and mortality risk reduction remains unclear due to conflicting study findings. Methods: We conducted a systematic review and meta-analysis ...

    • closedAccess   β-Blocker Withdrawal and Functional Capacity Improvement in Patients With Heart Failure With Preserved Ejection Fraction 

      Palau, Patricia; De la Espriella, Rafael; Seller, Julia; Santas, Enrique; Domínguez Mafé, Eloy; VV.AA. American Medical Association (2024-02-07)
      Importance: Increasing the patient's heart rate (HR) has emerged as a therapeutic option in patients with heart failure with preserved ejection fraction (HFpEF). However, the evidence is conflicting, and the profile of ...